Sionna Therapeutics (SION) Change in Account Payables (2024 - 2026)

Sionna Therapeutics has disclosed Change in Account Payables across 3 years of filings, most recently posting $1.2 million for Q1 2026.

• Change in Account Payables for Q1 2026 came in at $1.2 million, down 65.98% year-over-year; the trailing twelve-month figure through Mar 2026 was -$2.8 million (down 217.48% YoY), and the FY2025 annual result was -$417000.0, down 189.29% from the prior year.
• Change in Account Payables came in at $1.2 million for Q1 2026 at Sionna Therapeutics, up from -$712000.0 in the prior quarter.
• In the past five years, Change in Account Payables ranged from a high of $3.6 million in Q1 2025 to a low of -$3.8 million in Q2 2025.
• The 3-year median for Change in Account Payables is $567000.0 (2025), against an average of $139888.9.
• Peak annual rise in Change in Account Payables reached 132.22% in 2025, while the deepest fall reached 628.76% in 2025.
• Sionna Therapeutics' Change in Account Payables stood at $1.1 million in 2024, then sank by 165.8% to -$712000.0 in 2025, then soared by 269.8% to $1.2 million in 2026.
• The last three Change in Account Payables figures came in at $1.2 million (Q1 2026), -$712000.0 (Q4 2025), and $567000.0 (Q3 2025), per Business Quant data.